Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform. read more
Steve Doberstein ā SVP Research and Development and Chief R&D Officer at Nektar Therapeutics
Executive Bio
Steve Doberstein serves as the SVP Research and Development and Chief R&D Officer of Nektar Therapeutics. Steve started at Nektar Therapeutics in November of 2017. Steve currently resides in the San Francisco Bay Area.
Executive Team Culture Ratings from Nektar Therapeutics Employees
BOTTOM
20%
Nektar Therapeutics' Executive Team scores in the Bottom 20%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Nektar TherapeuticsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Nektar TherapeuticsNektar Therapeutics' Executive Team at a Glance
Based on 8 ratings, Nektar Therapeutics' employees are less satisfied with their Executive Team and give them a āDā or 54/100.
Nektar Therapeutics' Executive Team ranks in the Bottom 15% of other companies in San Francisco and Bottom 20% of other companies on Comparably that also have 501-1,000 Employees.
×